…
Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Herbalife Nutrition Ltd is a global direct-selling company that develops and distributes weight‑management, nutrition and personal‑care products through independent distributors. Long-term growth drivers include secular health-and-wellness demand, emerging‑market expansion and e‑commerce adoption. Investors may find the business appealing for its repeat‑purchase revenue profile and geographically diversified distribution network.
The principal investment risk is sustained regulatory, legal and reputational exposure stemming from its multi‑level marketing model and heavy reliance on independent distributors.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 275.10M | 169.40M | 203.00M | 424.80M | 560.80M |
| Minority interest | 0.50M | 0.00M | 0.00M | - | - |
| Net income | 228.30M | 254.30M | 142.20M | 321.30M | 447.20M |
| Selling general administrative | 1664.30M | 1725.60M | 1701.00M | 1810.40M | 2012.10M |
| Selling and marketing expenses | 1782.40M | 1782.80M | 1824.20M | - | - |
| Gross profit | 3808.90M | 3888.80M | 3871.40M | 4030.80M | 4563.50M |
| Reconciled depreciation | 121.20M | 121.40M | 113.30M | 115.40M | 107.60M |
| Ebit | 489.50M | 387.70M | 368.90M | 545.20M | 734.10M |
| Ebitda | 610.70M | 509.10M | 482.20M | 673.40M | 817.10M |
| Depreciation and amortization | 121.20M | 121.40M | 113.30M | 128.20M | 83.00M |
| Non operating income net other | - | - | - | 12.80M | 24.60M |
| Operating income | 441.50M | 385.90M | 356.40M | 545.20M | 734.10M |
| Other operating expenses | 4596.00M | 4607.20M | 4706.00M | 4659.20M | 5068.70M |
| Interest expense | 214.40M | 218.30M | 165.90M | 133.20M | 148.70M |
| Tax provision | 47.30M | -84.90M | 63.30M | 103.50M | 113.60M |
| Interest income | 205.90M | 12.30M | 9.80M | 6.10M | 148.70M |
| Net interest income | -205.90M | -206.00M | -153.60M | -133.20M | -148.70M |
| Non recurring | - | - | - | 1690.10M | 1833.70M |
| Income tax expense | 46.80M | -84.90M | 60.80M | 103.50M | 113.60M |
| Total revenue | 5037.50M | 4993.10M | 5062.40M | 5204.40M | 5802.80M |
| Total operating expenses | 3367.40M | 3502.90M | 3515.00M | 3485.60M | 3829.40M |
| Cost of revenue | 1228.60M | 1104.30M | 1191.00M | 1173.60M | 1239.30M |
| Total other income expense net | -166.40M | -216.50M | -153.40M | -120.40M | -173.30M |
| Net income from continuing ops | 227.80M | 254.30M | 186.40M | 321.30M | 447.20M |
| Net income applicable to common shares | 228.30M | 254.30M | 142.20M | 321.30M | 447.20M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2785.90M | 2728.10M | 2809.40M | 2732.00M | 2819.80M |
| Intangible assets | 315.10M | 312.30M | 314.00M | 315.70M | 317.30M |
| Other current assets | 188.00M | 184.10M | 237.70M | 196.80M | 187.70M |
| Total liab | 3295.30M | 3529.20M | 3869.70M | 3997.90M | 4211.30M |
| Total stockholder equity | -515.10M | -801.10M | -1060.30M | -1265.90M | -1391.50M |
| Other current liab | 856.70M | 749.60M | 768.40M | 803.40M | 896.00M |
| Common stock | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M |
| Capital stock | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M |
| Retained earnings | -579.70M | -808.00M | -1062.30M | -1204.50M | -1169.00M |
| Other liab | - | - | - | 166.40M | 196.50M |
| Good will | 100.50M | 87.70M | 95.40M | 93.20M | 95.40M |
| Other assets | 609.60M | 538.50M | 308.40M | 273.60M | 313.20M |
| Cash | 353.10M | 415.30M | 575.20M | 508.00M | 601.50M |
| Cash and equivalents | 353.10M | 415.30M | 575.20M | 508.00M | 601.50M |
| Total current liabilities | 1012.90M | 1230.40M | 1277.60M | 976.60M | 1080.40M |
| Current deferred revenue | - | 75.00M | 64.00M | 53.90M | 63.00M |
| Net debt | 1986.40M | 2054.00M | 2194.30M | 2376.40M | 2362.30M |
| Short term debt | 56.40M | 323.20M | 349.00M | 29.50M | 29.40M |
| Short long term debt | 20.90M | 283.50M | 309.50M | 28.90M | 29.00M |
| Short long term debt total | 2339.50M | 2469.30M | 2769.50M | 2884.40M | 2963.80M |
| Other stockholder equity | 316.00M | 278.20M | 233.90M | 188.70M | -10.80M |
| Property plant equipment | 616.00M | 645.90M | 692.30M | 486.30M | 442.10M |
| Total current assets | 1144.70M | 1143.70M | 1399.30M | 1356.10M | 1431.80M |
| Net tangible assets | - | - | - | -1674.80M | -1804.20M |
| Short term investments | - | - | -38.90M | - | - |
| Net receivables | 91.90M | 68.90M | 81.20M | 70.60M | 66.90M |
| Long term debt | 1970.10M | 1976.60M | 2252.90M | 2661.80M | 2733.20M |
| Inventory | 511.70M | 475.40M | 505.20M | 580.70M | 575.70M |
| Accounts payable | 99.80M | 70.00M | 84.00M | 89.80M | 92.00M |
| Accumulated other comprehensive income | -251.50M | -271.40M | -232.00M | -250.20M | -211.80M |
| Common stock total equity | - | - | - | 0.10M | 0.10M |
| Retained earnings total equity | - | - | - | -1204.50M | -1169.00M |
| Treasury stock | - | - | - | - | -328.90M |
| Non currrent assets other | 120.80M | 121.40M | 129.10M | 273.60M | 313.20M |
| Non current assets total | 1641.20M | 1584.40M | 1410.10M | 1375.90M | 1388.00M |
| Capital lease obligations | 191.20M | 209.20M | 207.10M | 231.10M | 245.10M |
| Long term debt total | 1971.70M | 1976.60M | 2252.90M | 2662.50M | 2733.20M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -84.60M | -142.40M | -156.20M | -156.40M |
| Change to liabilities | - | - | - | -54.70M | -61.90M |
| Total cashflows from investing activities | -108.70M | -84.60M | -134.80M | -156.20M | -156.40M |
| Net borrowings | -284.10M | -305.50M | -138.70M | -122.20M | 278.50M |
| Total cash from financing activities | -295.50M | -335.30M | -148.30M | -264.70M | -728.60M |
| Change to operating activities | - | - | - | -44.50M | -105.70M |
| Net income | 227.80M | 254.30M | 142.20M | 321.30M | 447.20M |
| Change in cash | -62.80M | -157.40M | 79.20M | -94.10M | -443.60M |
| Begin period cash flow | 438.10M | 595.50M | 516.30M | 610.40M | 1054.00M |
| End period cash flow | 375.30M | 438.10M | 595.50M | 516.30M | 610.40M |
| Total cash from operating activities | 333.30M | 285.40M | 357.50M | 352.50M | 460.30M |
| Depreciation | 121.20M | 121.40M | 113.30M | 115.40M | 107.60M |
| Other cashflows from investing activities | -28.30M | 37.40M | 0.20M | 0.20M | -5.00M |
| Change to inventory | -27.90M | -30.40M | 57.50M | -68.40M | -129.10M |
| Change to account receivables | -19.70M | 5.90M | -9.10M | -9.10M | -90.70M |
| Sale purchase of stock | -8.20M | -8.30M | -11.00M | -146.70M | -1011.30M |
| Other cashflows from financing activities | -3.10M | -21.50M | 1.40M | 838.70M | 1266.90M |
| Change to netincome | - | - | - | 23.10M | 79.40M |
| Capital expenditures | 80.40M | 122.00M | 135.00M | 156.40M | 151.40M |
| Change receivables | - | - | - | -9.10M | 9.60M |
| Cash flows other operating | - | - | - | 18.20M | -22.60M |
| Cash and cash equivalents changes | - | - | - | -68.40M | -424.70M |
| Change in working capital | -35.50M | 32.50M | 47.70M | -123.10M | -218.30M |
| Stock based compensation | 44.10M | 50.00M | 48.00M | 44.40M | 54.10M |
| Other non cash items | 39.90M | 56.80M | 47.40M | 24.40M | 103.00M |
| Free cash flow | 252.90M | 163.40M | 222.50M | 196.10M | 308.90M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HLF Herbalife Nutrition Ltd |
1.10 8.28% |
14.38 | 7.65 | 3.89 | 0.24 | 31.19 | 0.60 | 5.87 |
| NSRGF Nestle SA |
3.65 3.63% |
104.28 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-0.95 0.92% |
102.44 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
-0.12 0.81% |
14.71 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
-0.26 0.35% |
73.62 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
P.O. Box 80210, Los Angeles, CA, United States, 90080-0210
310 410 9600
8500
| Name | Title | Year Born |
|---|---|---|
| Mr. John G. DeSimone | Pres | 1967 |
| Mr. Alexander R. Amezquita | Chief Financial Officer | 1974 |
| Mr. Mark J. Schissel | Chief Operating Officer | 1969 |
| Mr. Michael O. Johnson | Chairman & Interim CEO | 1955 |
| Ms. Susan B. Peterson | Founder | NA |
| Mr. Bobby J. Irani | Sr. VP & Principal Accounting Officer | NA |
| Ms. Rhonda M. Vetere | Exec. VP & Chief Information Officer | NA |
| Bill Ferrante | Sr. VP of Fin., Strategy & Investor Relations | NA |
| Mr. Henry C. Wang | Exec. VP, Gen. Counsel & Corp. Sec. | 1970 |
| Mr. Andrew J. Dunbar J.D. | Sr. VP & Chief Compliance Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.